BackCowealth Medical Holding , Ltd. Overview

Cowealth Medical Holding , Ltd. EBIT

Cowealth Medical Holding , Ltd.'s EBIT is $-300M, below the sector sector average of $-25M.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$45.41M
↓ 63.01% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$304.44M
↓ 2499.81% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Cowealth Medical Holding , Ltd. (4745.TWO) FAQ

The latest EBIT for 4745.TWO is $-300M as of June 2026. That compares with $-12M in the prior-year period — down 2499.8% year over year. That is below the sector sector average of $-25M. Investors often review this figure alongside Cowealth Medical Holding , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 4745.TWO's EBIT moved from $-12M to $-300M — a 2499.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cowealth Medical Holding , Ltd.'s operating scale or balance-sheet position.

Against its sector companies, 4745.TWO currently prints $-300M for EBIT, while the sector average sits near $-25M. That is roughly 1101.5% below the sector mean. Large gaps often invite a closer look at Cowealth Medical Holding , Ltd.'s growth, margins, and balance sheet.

A EBIT figure of $-300M for 4745.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-25M. Explore the charts below for those layers of context.

After noting 4745.TWO's EBIT ($-300M), review year-over-year change from $-12M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.